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Although the association of smoking and some mental disorders 
(e.g., depressive disorders) has been increasingly recognized 
(Ziedonis et al., 2008), the relationship between personality 
disorders (PDs) and cigarette use has received less attention. 
Most of the studies were performed in smokers from the general 
population (individuals enrolled voluntarily in a research study 
but who were not seeking treatment) and few were carried out in 
clinical samples (individuals seeking treatment to quit smoking). 
This appreciation is important because there are some differences 
between smokers from both groups regarding demographics 
(age, gender, etc.) and smoking-related characteristics (including 
nicotine dependence, ND) (Hughes, Giovino, Klevens, & Fiore, 
1997; Le Strat, Rehm, & Le Foll, 2011). Research indicated that 
female, older age, more educated, and more nicotine-dependent 
smokers were more likely to attend treatments (pharmacological 
and non-pharmacological) to stop smoking (e.g., Kotz, Fidler, & 
West, 2009). It seems that smokers with high ND are more likely 
to seek treatment because of a greater risk of failure if they try 
to quit without treatment (e.g., Shiffman, Brockwell, Pillitteri, & 
Gitchell, 2008). 
Regarding the relationship between PDs and smoking, previous 
research among smokers from the general population has reported 
important fi ndings. First, this association appears to differ by 
specifi c PD, with some of the strongest relations being evident for 
antisocial (e.g., Becoña, Fernández del Río, López-Durán, Piñeiro, 
& Martínez, 2013; Zvolensky, Jenkins, Johnson, & Goodwin, 
2011) and borderline PDs (Donald, Chartrand, & Bolton, 2013). 
Second, although ND is a key issue in the smoking fi eld, it has not 
always been assessed in the studies about the relationship between 
PD and cigarette use. For example, Zvolensky et al. (2011) found 
a modest association between smoking without ND and PDs, with 
the exception of antisocial PD. However, when ND was assessed, 
odds ratios increased signifi cantly for all PDs. Becoña et al. (2013) 
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Abstract Resumen
Background: There is consistent evidence about the relationship between 
smoking and mental health. This study compares the relationship between 
tobacco use and personality disorders (PDs) in Spanish adults from 
general and clinical population, taking into account nicotine dependence 
(ND), and the presence of any mental disorder. Method: The sample was 
made up of 1,079 smokers (519 from general population, 560 from clinical 
population). PDs were assessed by means of the International Personality 
Disorder Examination Questionnaire, Module DSM-IV. Results: 
Individuals seeking treatment to quit smoking had a higher likelihood of 
presenting a paranoid, schizoid, schizotypal, borderline, antisocial, and 
dependent PD compared to smokers from the general population. This 
likelihood was higher when ND was taken into account. Among smokers 
from the general population, ND was associated with a higher likelihood 
of presenting a borderline and dependent PD. Conclusions: A signifi cant 
relationship between smoking and several PDs exist, especially in nicotine 
dependent smokers. Relevance of the fi ndings regarding the infl uence of 
PDs in smoking cessation interventions is discussed.
Keywords: Personality disorders, smoking, tobacco.
Trastornos de personalidad y consumo de tabaco en la población 
general y clínica española. Antecedentes: existe evidencia sólida sobre 
la relación entre fumar y salud mental. Este estudio compara la relación 
entre consumo de tabaco y trastornos de personalidad (TP) en adultos 
españoles de población general y población clínica, teniendo en cuenta 
la dependencia de la nicotina (DN)  y la presencia de algún trastorno 
mental. Método: la muestra estuvo formada por 1.079 fumadores (519 
de población general, 560 de población clínica). Los TP se evaluaron 
con el cuestionario del International Personality Disorders Examination, 
Módulo DSM-IV. Resultados: los individuos que demandaron tratamiento 
para dejar de fumar tenían una mayor probabilidad de presentar un TP 
paranoide, esquizoide, esquizotípico, límite, antisocial y dependiente que 
los fumadores de población general. Esta probabilidad fue mayor cuando 
además existía DN. Entre los fumadores de población general, la DN se 
asoció con una mayor probabilidad de presentar un TP límite y dependiente. 
Conclusiones: existe una relación signifi cativa entre consumo de tabaco 
y varios TP, especialmente en fumadores dependientes de la nicotina. Se 
comenta la relevancia de los hallazgos respecto a la infl uencia de los TP 
en las intervenciones para dejar de fumar.
Palabras clave: trastornos de personalidad, fumar, tabaco.
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confi rmed that individuals with a paranoid, narcissistic, antisocial, 
or borderline PD had a higher likelihood for being current smokers, 
with signifi cantly higher odds when they took into account ND. 
Finally, previous research has also found that comorbid mental 
disorders could partly explain the relationship between PDs and 
cigarette use (e.g., Afi fi  et al., 2011; Jackson & Burgess, 2004). For 
example, the strength of the observed association between paranoid 
and schizoid PD (Zvolensky et al., 2011) or borderline PD (Becoña 
et al., 2013) was attenuated after taking into account the presence 
of other mental disorders (e.g., mood, anxiety disorders).
Findings regarding the relationship between PDs and smoking 
in people seeking smoking cessation treatment are contradictory. 
For instance, Gariti, Alterman, Mulvaney, and Epperson (2000) 
did not fi nd signifi cant differences in a combined treatment 
(psychosocial and pharmacological) for smoking cessation 
between smokers with or without any PD. However, a recent 
study carried out in Spanish smokers pointed out that borderline, 
antisocial, or avoidant PDs were associated with lower cessation 
rates, whereas schizoid PD was related to the maintenance of 
abstinence (Piñeiro, Fernández del Río, López-Durán, Martínez, 
& Becoña, 2013).
So, due to the existence of differences between smokers 
from both populations and the potentially confounding effect 
of psychiatric comorbidity and ND in the relationship between 
PDs and cigarette use, there is a clear need to analyze deeply 
this association. The aim of the present study was to compare the 
presence of PDs in Spanish smokers from general and clinical 
population, taking into account ND and the presence of any 
lifetime mental disorder. 
Method
Participants 
 
This study was carried out in two samples of Spanish smokers 
aged 18 or older. The clinical sample was formed of participants 
seeking  psychological treatment for smoking cessation at the 
Smoking Cessation and Addictive Disorders Unit of the Faculty 
of Psychology at the University of Santiago de Compostela 
(January 2009-December 2013). The inclusion criteria were: age 
18 or over; a wish to participate in the treatment; smoking 10 or 
more cigarettes per day, and having completed the pretreatment 
assessment questionnaires. Exclusion criteria were: diagnosis 
of a severe mental disorder (bipolar and/or psychotic disorder), 
concurrent dependence on other substances, having participated 
in the same or similar treatment over the previous year, having 
received another type of effective smoking cessation treatment 
(nicotine replacement therapy, bupropion, varenicline) in the 
previous year, suffering from a physical pathology with a high 
life risk which would require immediate individual intervention 
(e.g., recent myocardial infarction), smoking tobacco other than 
cigarettes (e.g., cigars), refusing to be video-recorded during the 
treatment sessions, and failing to attend the fi rst treatment session. 
From an initial sample of 680 smokers, 68 were excluded based on 
inclusion and exclusion criteria, with the fi nal sample comprising 
560 smokers (41.1% men and 58.9% women) with a mean age of 
41.45 years (SD = 10.46, range 19-86).
Details of the sampling frame of participants from the general 
population who did not seek treatment to stop smoking are 
described elsewhere (see Becoña et al., 2013). Smokers from the 
general population were personally interviewed in their homes 
between June 2009 and July 2010. Inclusion criteria were: age 18 
or over, smoking at least 1 cigarette per day in the last month, and 
having completed the questionnaires. The fi nal sample comprised 
519 smokers (53.2% men and 46.8% women) with a mean age of 
43.24 years (SD = 16.13, range 18-85).
Sample description about sociodemographics, smoking-related 
variables, mental health history, and PDs are presented in Table 1.
Instruments
 
Sociodemographic information (gender, age, educational 
level, and marital status) and smoking-related variables were 
assessed. ND was assessed by means of the Fagerström Test for 
Nicotine Dependence (FTND, Heatherton, Kozlowski, Frecker, & 
Fagerström, 1991; Spanish version by Becoña & Vázquez, 1998). 
A cut-off point of six or more was used. The reliability obtained 
by means of Cronbach’s alpha was .70.
Mental health history was determined by whether smokers 
indicated suffering any lifetime mental disorder (0 = no, 1 = yes). 
We also assessed whether participants had ever received treatment 
for depression (0 = no, 1 = yes). 
For the assessment of PDs, the International Personality 
Disorder Examination Questionnaire, IPDEQ, DSM-IV module 
(a self-report screening instrument comprising 77 items in true–
false response format), was used (Loranger, 1995; Spanish version 
by López-Ibor, Pérez-Urdániz, & Rubio, 1996). Loranger, Janca, 
and Sartorius (1997) established a cut-off point of three or more 
positive items for considering a PD as probable, but this very 
low cut-off point notably increases the number of false positives 
at the cost of increasing the sensitivity of the instrument. With 
the aim of increasing the specifi city of the IPDEQ, we used the 
diagnostic criteria established by the DSM-IV for each PD as the 
cut-off points, in line with previous studies (Fernández del Río, 
Martínez-Vispo, & Becoña, 2011; Lewin, Slade, Andrews, Carr, 
& Hornabrook, 2005). Therefore,  the cut-off points vary from 
three to fi ve positive criteria: three corresponds to an antisocial 
disorder, four to a paranoid, schizoid, obsessive-compulsive 
and avoidant disorder, and fi ve to a schizotypal, histrionic, 
narcissistic, borderline, and dependent PD (Fernández del Río 
et al., 2011).
Procedure
Participants from the clinical sample were initially assessed 
when they requested psychological treatment for smoking 
cessation. The psychological treatment administered was the 
Smoking Cessation Program by Becoña (2007), a manualized 
cognitive-behavioral treatment that comprises 6 group-format 
sessions over six weeks (one session per week). 
The general population sample is a representative sample 
of adults from 13 cities in Galicia (Spain) stratifi ed by gender 
and age. The streets from which the sample was recruited were 
randomly selected. The fi rst inhabited house in each street was 
selected randomly to begin the recruitment. Before interviewing 
the participants, interviewers had to check that they had been 
living there for at least six months, inform them about the aims 
of the study and obtain their informed consent to participate. 
All the interviews were carried out face-to-face by psychologists 
especially trained for that purpose.
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All the participants, from general and clinical populations, 
gave their informed consent for participation, and the study 
was authorized by the Bioethics Committee of the University of 
Santiago de Compostela (Spain).
Data analysis
Analyses were carried out using PASW Statistics 18. Cross-
tabulations were calculated to determine the prevalence of cigarette 
smokers with specifi c PDs, including non-dependent and dependent 
smokers from both samples. Chi-square analyses with Bonferroni 
correction were carried out on bivariate analyses. Differences were 
considered statistically signifi cant at p<.05 (p<.025 or p<.016 for 
chi-square with Bonferroni correction). Odds ratios (ORs) were 
then derived to establish the association between PDs and type of 
population (general, clinical). Next, adjusted odds ratios (AOR) 
were calculated adjusting for sociodemographics (gender, age, 
marital status, and educational level) and for any mental disorder 
and for lifetime treatment for depression.
Results
Differences among smokers according to the type of population
The comparison between smokers from the general and the 
clinical population revealed signifi cant differences according to 
sociodemographics, smoking-related variables, mental health 
history, and PDs (see Table 1). The results revealed that smokers 
seeking smoking cessation treatment were mainly women and had a 
higher level of education. They also began smoking at an earlier age, 
smoked more cigarettes/day, had a higher level of ND, had a greater 
desire to stop smoking, and were more motivated to quit smoking 
than smokers from the general population. According to mental 
health, a higher percentage of smokers from the clinical sample than 
from the general population had experienced any lifetime mental 
disorder and had received treatment for depression in the past.
Regarding PDs, the percentage of paranoid, schizoid, 
schizotypal, antisocial, borderline and dependent PDs were 
signifi cantly higher among smokers seeking psychological 
treatment to quit smoking than among smokers from the general 
population. However, avoidant PD was more prevalent among 
smokers who did not seek treatment to quit smoking.
Association between type of population (general vs. clinical), ND 
and PDs
 
Participants from the clinical population presented higher odd 
ratios of paranoid, schizoid, schizotypal, borderline, antisocial, 
and dependent PDs, adjusted for demographics and for lifetime 
mental disorder and lifetime treatment for depression (see Table 2) 
Table 1
Sociodemographics, smoking-related variables, mental health history, and PDs in general and clinical samples
Clinical population
(n = 560)
General population
 (n = 519)
χ2 / t Cramer’s V/ Cohen’s d
Sociodemographics
Gender (male) 41.1 53.2 15.86*** .12
Age (40 or less) 45.5 47.2 0.30
Marital status (married) 50.2 54.1 7.27
Educational level (high) 43.1 14.5 109.32*** .32
Smoking-related variables
Age at initiation of smoking 17.93 (4.05) 19.09 (5.15) -4.08*** -.26
No. of cigarettes smoked per day 21.33 (8.17) 15.44 (9.58) 10.84*** .68
FTND (score 6 or more) 45.9 11.4 155.04*** .38
Desire to stop smoking (0-10) 8.79 (1.59) 4.85 (3.86) 21.67*** 1.66
Stage of readiness to quit (preparation) 25.4 3.5 533.31*** .70
Mental Health
Lifetime mental disorder (yes) 43.4 12.5 125.99*** .34
Lifetime Treatment for Depression (yes) 38.9 12.7 95.43*** .30
PDs (yes)
Paranoid 27.1 10.8 45.85*** .21
Schizoid 72.9 7.9 468.21*** .66
Schizotypal 9.1 1.3 31.96*** .17
Histrionic 14.5 11.4 2.32
Antisocial 33.2 9.2 90.64*** .29
Narcissistic 12.6 9.8 2.02
Borderline 21.4 9.6 28.23*** .16
Obsessive-compulsive 31.6 38.3 5.38* .07
Dependent 10.6 5.2 10.50*** .10
Avoidant 36.9 31.4 3.54
FTND: Fagerström Test for Nicotine Dependence
Means (SD) presented for continuous variables and percentages presented for categorical variables
* p<.025 (Bonferroni correction), *** p<.001
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compared to non-dependent smokers from the general population. 
Odds ratios were higher when smokers were nicotine dependent, 
except in the case of paranoid PD, where AORs were similar. 
Regarding borderline and dependent PDs, we also found that 
nicotine-dependent smokers from the general population presented 
these PDs to a greater extent than non-nicotine-dependent 
smokers.  The likelihood of presenting an avoidant PD was only 
higher in nicotine-dependent smokers seeking smoking cessation 
treatment when compared to non-dependent smokers from the 
general population. In contrast, we found that non-dependent 
smokers from the clinical population had a lower likelihood of 
presenting an obsessive compulsive PD compared to the non-
dependent smokers from the general population. There was no 
signifi cant association between current smoking, with or without 
ND, type of population, and histrionic or narcissistic PDs.
Discussion
 
The purpose of the present study was to compare the presence of 
PDs in Spanish smokers from the general and clinical population, 
taking into account ND and the presence of any lifetime mental 
disorder. Results indicated that participants seeking treatment to 
quit smoking had a higher likelihood of presenting a paranoid, 
schizoid, schizotypal, borderline, antisocial, and dependent PD, 
compared to smokers from the general population. These fi ndings 
are consistent with those of previous research suggesting a greater 
use of mental health resources by people with PDs (Bender et al., 
2001). As an explanation for this increased demand for treatment, 
Ansell, Sanislow, McGlashan, and Grilo (2007) pointed out that 
people with a PD, especially borderline PD, are characterized 
by higher detrimental impacts on daily functioning and lower 
quality of life than people without mental disorder diagnosis. 
An alternative explanation is the one mentioned by Powers and 
Oltmanns (2013), who concluded that people with paranoid, 
schizoid, schizotypal, borderline, antisocial, and avoidant PDs 
have a worse health perception and, therefore, they require more 
health care.
ND seems to be a key variable associated with PDs. Findings 
showed that the likelihood  of presenting a paranoid, schizoid, 
schizotypal, borderline, antisocial, and dependent PD increases 
Table 2
PDs, group of reference, smoking, and ND
No paranoid 
PD
Paranoid PD
OR 
(95% CI)
AORa 
(95%CI)
AOR1a
(95%CI)
No schizoid 
PD
Schizoid PD
OR 
(95% CI)
AORa 
(95%CI)
AOR1a
 (95%CI)
No 
schizotypal 
PD
Schizotypal  
PD
OR 
(95% CI)
AORa 
(95%CI)
AOR1a
(95%CI)
Smoker 
GP, no ND 
(Ref)
47.5 
(413)
22.7 
(47)
1.00 1.00 1.00
67.4 
(424)
8.0 
(36)
1.00 1.00 1.00
44.5 
(454)
10.3 
(6)
1.00 1.00 1.00
Smoker 
GP, ND
5.7 
(50)
4.3
 (9)
1.58  
 (0.73-3.42)
1.54
(0.71-3.35)
1.46             
(0.67-3.18)
8.6
 (54)
1.1 
(5)
1.09          
(0.41-2.90)
1.10     
 (0.41-2.94)
1.12              
(0.42-2.98)
5.7 
(58)
1.7 
(1)
1.31                   
(0.15-11.03)
1.23           
(0.15-10.44)
1.11              
(0.13-9.45)
Smoker 
CP, no 
ND
25.4 
(221)
39.6 
(82)
3.26***  
(2.20-4.84)
3.26***
(2.15-4.94)
2.92***              
(1.91-4.47)
13.2 
(83)
48.9 
(219)
31.08*** 
(20.34-47.48)
30.13*** 
(19.39-46.82)
31.07***    
(19.75-48.86)
27.3 
(278)
41.4 
(24)
6.53***            
(2.64-16.18)
7.67***     
(3.02-19.45)
6.44***        
(2.50-16.60)
Smoker 
CP, ND
21.4
 (186)
33.3 
(69)
3.26***
 (2.17-4.91)
3.14***
(2.06-4.78)
2.68***          
(1.72-4.17)
10.8 
(68)
42.0 
(188)
32.56*** 
(20.99-50.51)
31.92***  
(20.40-49.96)
33.52***     
(20.90-53.77)
22.5
 (230)
46.6 
(27)
8.88***            
(3.62-21.82)
9.63***     
(3.85-24.05)
7.45***        
(2.88-19.24)
No borderline PD Borderline  PD
OR 
(95% CI)
AORa 
(95%CI)
AOR1a
(95%CI)
No antisocial PD Antisocial PD
OR 
(95% CI)
AORa 
(95%CI)
AOR1a
(95%CI)
Smoker 
GP, no ND 
(Ref)
46.6 
(424)
21.2 
(36)
1.00 1.00 1.00
50.0 
(422)
16.3 
(38)
1.00 1.00 1.00
Smoker 
GP, ND
5.0 
(45)
8.2 
(14)
3.66***        
 (1.84-7.30)
3.61*** 
(1.80-7.23)
3.20**
(1.57-6.50)
5.8 
(49)
4.3 
(10)
2.27*                
(1.06-4.83)
2.18*                         
(1.01-4.70)
2.02                                  
(0.92-4.40)
Smoker 
CP, no 
ND
27.8 
(253)
29.4
 (50)
2.33***            
(1.48-3.67)
2.48***
(1.54-3.99)
1.88*
(1.15-3.07)
25.2
 (213)
38.6
 (90)
4.69***            
(3.10-7.09)
5.62***                     
(3.62-8.72)
4.87***                     
(3.11-7.62)
Smoker 
CP, ND
20.6 
(187)
41.2
 (70)
4.41***           
 (2.85-6.83)
4.49***
(2.87-7.05)
3.04***
(1.89-4.91)
19.0 
(160)
40.8 
(95)
6.59***            
(4.34-10.01)
7.78***                      
(5.02-12.06)
6.18***                     
(3.91-9.76)
No avoidant 
PD
Avoidant PD
OR 
(95% CI)
AORa 
(95%CI)
AOR1a
(95%CI)
No dependent 
PD
Dependent PD
OR 
(95% CI)
AORa 
(95%CI)
AOR1a
(95%CI)
No obsessive-
compulsive 
PD
Obsessive-
compulsive PD
OR 
(95% CI)
AORa 
(95%CI)
AOR1a
(95%CI)
Smoker 
GP, no ND 
(Ref)
44.7
 (317)
38.8 
(143)
1.00 1.00 1.00
44.6
 (442)
20.9 
(18)
1.00 1.00 1.00
40.3 
(283)
47.1 
(177)
1.00 1.00 1.00
Smoker 
GP, ND
5.5 
(39)
5.4 
(20)
1.14      
 (0.64-2.02)
0.96     
(0.53-1.74)
1.06
(0.59-1.90)
5.0 
(50)
10.5
 (9)
4.42**
 (1.89-10.36)
4.12**       
(1.75-9.71)
3.81**      
(1.61-9.03)
5.3 
(37)
5.9 
(22)
0.95          
(0.54-1.66)
0.94                
(0.53-1.66)
0.89           
(0.50-1.57)
Smoker 
CP, no 
ND
28.2
 (200)
27.9
 (103)
1.14      
 (0.84-1.56)
1.04     
(0.74-1.47)
1.26
(0.91-1.76)
28.0 
(278)
29.1 
(25)
2.21* 
(1.18-4.12)
2.50**         
(1.31-4.78)
2.09*         
(1.07-4.07)
31.4 
(221)
21.8 
(82)
0.59**     
(0.43-0.81)
0.54**             
(0.38-0.75)
0.48***        
(0.34-0.68)
Smoker 
CP, ND
21.6 
(153)
27.9 
(103)
1.49*           
(1.09-2.05)
1.19
 (0.83-1.70)
1.55**
(1.11-2.15)
22.4 
(222)
39.5 
(34)
3.76***
(2.08-6.81)
3.82***         
(2.08-7.02)
3.01**         
(1.58-5.74)
23.0
 (162)
25.3 
(95)
0.94         
(0.68-1.29)
0.84                 
(0.60-1.16)
0.71             
(0.50-1.00)
GP = General Population; CP = Clinical Population; AOR, Adjusted Odds Ratios; 95%CI, 95% confi dence intervals.  Reference categories for each variable are identifi ed with (Ref )
AORa = adjusted for age, gender, marital status, educational level. AOR1= adjusted for any mental disorder and lifetime treatment for depression
* p<.05; ** p<.01; *** p<.001
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further when individuals who seek treatment to quit smoking are 
nicotine dependent, even after adjusting for the presence of any 
lifetime mental disorder and lifetime treatment for depression. 
Previous research has indicated that there is a strong relationship 
between ND and several PDs such as antisocial (Zvolensky et 
al., 2011) or schizotypal (Pulay et al., 2010). The studies (e.g., 
Brook, Zhang, Balka, Seltzer, & Brook, 2013) indicate the need 
to take into account certain personality traits such as low self-
control, high resistance to rules, impulsivity and sensation-
seeking (characteristics of both antisocial and borderline PDs) in 
smoking cessation programs because resistance to rules and ND 
are positively associated with each other, which would partially 
explain the diffi culties to quit for people with antisocial and 
borderline PDs. 
We have found that ND is also relevant in the relation between 
certain PDs and cigarette use in individuals from the general 
population: nicotine-dependent smokers had a higher likelihood 
of presenting borderline PD and dependent PD than non-nicotine-
dependent smokers, with odd ratios similar to those of nicotine 
dependent smokers of the clinical population.
Therefore, treatment-seeking smokers have a higher likelihood 
of presenting a PD than smokers from the general population, and 
this likelihood is even higher if ND is present. However, it appears 
that obsessive-compulsive PD is an exception. The only signifi cant 
relationship that we found is that non-nicotine-dependent smokers 
seeking treatment had a lower likelihood of presenting an 
obsessive compulsive PD than non-nicotine-dependent smokers 
from the general population. Although they do not follow the 
same tendency as the rest of PDs, these results confi rm previous 
studies carried out by our team in the general population (Becoña 
et al., 2013) that indicate that non-nicotine dependent smokers, 
compared to never-smokers, have a greater likelihood of presenting 
an obsessive-compulsive PD. So, it appears that people with an 
obsessive-compulsive PD are less likely to seek smoking cessation 
treatment. Some characteristics of this PD (high conscientiousness, 
infl exibility, over-control, and perfectionism) could explain the 
existence of greater control over tobacco use, which implies a 
lower likelihood of becoming nicotine-dependent and, therefore, 
a lower need for smoking cessation treatment. We know that the 
greater the ND, the harder it is to quit smoking without help (Fiore 
et al., 2008), so nicotine dependent smokers would require more 
intensive interventions. 
Some limitations to this study should be noted. First, it would 
be advisable in future research to use the complete IPDE clinical 
interview or the SCID-II for PDs, and SCID-I for other mental 
disorders. But, in the case of general population, it is diffi cult to 
use this kind of instruments, given the assessment characteristics 
in this type of studies (e.g., limited time, place in which the 
assessment is conducted, etc.). Second, these results are only 
generalizable to adult Spanish smokers.
Despite these limitations, the current fi ndings are relevant 
and have direct clinical use in the context of smoking cessation 
interventions. Firstly, despite the population of smokers with mental 
disorders has received less attention (Rüther et al., 2014), our results 
indicate that they are interested in quitting smoking. Given that 
having a mental disorder is associated with a lower likelihood of 
quitting smoking (Donald et al., 2013) and that ND also makes 
it more diffi cult (Fiore et al., 2008), our results suggest the need 
to adapt smoking cessation programs to the characteristics of the 
population of smokers with mental disorders (e.g., Fernández del 
Río, López-Durán, & Becoña, 2011). Therefore, we should take into 
account the assessment of PDs in people seeking smoking cessation 
treatment  (e.g., Hasin et al., 2011), as well as to analyze the need 
to include specifi c components in the treatment that will increase 
the likelihood of quitting. Authors like Trull, Jahng, Tomko, Wood, 
and Sher (2010) concluded that people with a PD usually present 
substance use disorders, so it is important to take it into account for 
the assessment and treatment of smoking cessation. Finally, as in 
previous studies (Piñeiro et al., 2013), this study revealed differential 
(and opposing) relationships between specifi c PDs and smoking 
cessation outcomes (e.g., obsessive-compulsive PD), illustrating the 
need to consider PDs separately when analyzing their relationship 
with the consumption of substances such as tobacco.
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